Articles
| Open Access |
DOI: CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF PROSTATE CANCER
Hamza Abdukodirovich Rakhmanov , Assistant of department of pathological anatomy Samarkand State Medical Institute, Uzbekistan Shavkat Erjigitovich Islamov , Doctor of Medical Sciences, associate professor at the department of pathological anatomy Samarkand State Medical Institute, Uzbekistan Nodir Mukhammadievich Rahimov , Doctor of Medical Sciences, Assistant Professor, Department of Oncology Samarkand State Medical Institute, UzbekistanAbstract
The article highlights clinical and morphological characteristics of prostate cancer. The results of the carried out researches at the character study, pathogenesis of the development and diagnostics testify to the increase of number of so called "hormone-resistant" cases of the prostate cancer. It has been established that morphological diagnosis of prostate cancer is difficult, because signs of malignancy may be barely visible, which increases the probability of a false-negative result. At the same time there are many benign processes that mimic a malignant tumour, which can lead to misdiagnosis. In recent years, the use of immunohistological markers to detect basal layer cells has been recommended. Their level can be determined by immunohistochemical examination, which is elevated in prostate cancer.
Keywords
Prostate cancer, clinic, morphology
References
Bhojani N., Salomon L., Capitanio U., et al. External validation of the updated Partin tables in a cohort of French and Italian men.// Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol.73 - P.347-52.
Derweesh I.H., Kupelian P.A. Continuing trends in pathological stage migration in radical prostatectomy specimens. //Urol. Oncol. – 2004. - Jul-Aug; 22(4): - P. 300-6.
Eckersberger E., Finkelstein J., Sadri H., Margreiter M., Djavan B. et al Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials. //Reviews in Urology. - Vol. 11 № 3. - 2009. – Р. 127-133
Eble J.N. et al.: Pathology and Genetics: Tumors of the urinary system and male genital organs. WHO classification of tumors. World Health Organization, Geneva, - 2004. - 299 p.
Epstein J.I., Netto G.J. Biopsy Interpretation of the Prostate. Philadelphia, JB Lippincott Williams & Wilkins, 2008. ISBN9781469887517- 440 p.
Gretzer M.B., Partin A.W. PSA markers in prostate cancer detection. //Urol. Clin. North. Am. - 30, 2003. - 30 (4): - P. 677-86. doi: 10.1016/s0094-0143(03)00057-0.
Islamov Sh.E. Subjectivity in defects in rendering medical aid // European science review, Vienna, 2018. - №11-12. – P. 95-97.
Messing E.M., Manola J., Sarosdy M. et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer //N.Engl.J.Med. — 1999. — V. 341, № 9.— Р. 1781—1788.
Prayer-Galetti T., Zattoni F., Capizzi A. et al. Disease free survival in patients with pathological C stage prostate cancer at radical reropubic prostatectomy submitted to adjuvant hormonal treatment //Eur.Urol. — 2000. — V. 38. — Аbstr. 504.
Van de Kwast T. et al Single Prostatic Cancer Foci on Prostate Biopsy.// Eur Urol supp 7. 2008. – Р. 549-556.
Article Statistics
Copyright License
Copyright (c) 2022 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.